申请人:Kolczewski Sabine
公开号:US20100210592A1
公开(公告)日:2010-08-19
The invention relates to the use of compounds of formula I
wherein the substituents are described in the description and claims for the treatment of psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders or Alzheimer's disease. The invention also relates to some compounds of formula I and pharmaceutical compositions containing them.
本发明涉及使用式I中的化合物,其中取代基在描述和权利要求中描述,用于治疗精神病、记忆和学习功能障碍、精神分裂症、痴呆症、注意力缺陷障碍或阿尔茨海默病。本发明还涉及一些式I的化合物和含有它们的药物组合物。